is glp-1 insulin GLP-1: Actions on Beta-cell Mass and Function Mechanism of glucose-dependent, GLP1-potentiated insulin

Let the vial and bacteriostatic water reach room temperature

Please contact us to discuss your individual circumstance, so we can advise further

15 There are 31 secondary endpoints, including, achievement of 10, 15%, and 20% body weight reduction, and absolute changes from baseline to Week 76 in: 15 Body weight Waist circumference Blood pressure Body Mass Index (BMI) Glycosylated hemoglobin A1c (HbA1c) Total cholesterol Liver fat content Body composition sub study endpoints included absolute and relative change in: Total fat volume Lean body volume Visceral fat volume Subcutaneous fat volume About the SYNCHRONIZE-MASLD trial (NCT06309992) This is a Phase III, double-blind, placebo-controlled 48-week efficacy and safety trial of survodutide among 218 adults living with obesity and overweight and with MASLD with evidence of inflammation and or fibrosis versus placebo

As with any medical or wellness service, there is a possibility of mild side effects such as soreness at the injection site or temporary discomfort during infusion